The market sentiment is picking up, and Calliditas is interesting ahead of the critical PDUFA date (...
Intäkterna i Q2 slog marknadens förväntningar marginellt.
Redeye endorses the news that Curasight has appointed a CRO, ABX-CRO, to conduct the upcoming phase ...
Redeye is favorable to the news that Lifeclean has decided to improve its short-term financial posit...
Redeye comments on Enviro’s decision to appoint Fredrik Emilson as the new CEO.
Redeye provides a preview ahead of ES Energy Save’s (ES) Q2 2023/24 report, due on the 19th of Decem...
IRLAB has been granted a new patent for its Phase IIb asset, pirepemat, extending the predicted pate...
SBB presenterade i september en ny koncernstruktur som består av tre affärsenheter: Bostäder, Samhäl...
Redeye comments on Circio’s partner IOVaxis Therapeutics submission of an application to start a cli...
Redeye comments on Artificial Solutions’ rights issue of SEK25.
Redeye comments on Vertex's bid to buy Pagero for SEK36 per share, valuing the company at about SEK5...
Investmentbolaget Archelon investerar främst i prospekteringsbolag.
Redeye has a positive first impression of Neonode's press release of today, where the company announ...
Med ett kvartal kvar av år 2023 uppgår nettoomsättningen till 8,6 MSEK (1,6), vilket innebär en mång...
Qbrick genomför nu en företrädesemission mellan 7-21 december om 7,5 MSEK, där teckningsåtagandet up...
Redeye notes Mendus announcing that ADVANCE II’s mRFS amounted to c30.
Gabather, ett forskningsbolag specialiserade inom innovativa neurologiska terapier, inleder ett sama...
Redeye in this note provides a quick comment on Jondetech's changing of CEO that was announced earli...
Gabather genomför mellan den 6–20 december en företrädesemission om 28,6 MSEK.
CirChems kommersiella resa fortsätter och på rullande basis uppgår Bolagets intäkter nu till ca 2,6 ...
